Anti-Toxoplasma gondii secretory IgA in tears of patients with ocular toxoplasmosis: Immunodiagnostic validation by ELISA

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 6, 2009, Pages 818-822

  Lynch, Maria Isabel ^a,c   Malagueño, Elizabeth ^b   Lynch, Luiz Felipe ^a   Ferreira, Silvana ^b,c   Stheling, Raphael ^a,d   Oréfice, Fernando ^a,d  

^a Federal University of Pernambuco   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c UNIVERSIDADE DE PERNAMBUCO   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Lachrymal sIgA; Ocular toxoplasmosis; Toxoplasmosis immunodiagnostic

Indexed keywords

TOXOPLASMA GONDII;

EID: 70350294670     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000600003     Document Type: Article

References (29)

1. Belfort Jr R, Hirata OS, Abreu MT 1978. Uveítes: estudo de 250 casos consecutivos. Arq Bras Oftalmol 41: 196-199.
2. Borges AS, Figueiredo JF 2004. Detection of anti-Toxoplasma gondii IgG, IgM and IgA immunoglobulins in the serum, cerebrospinal fluid and saliva of patients with acquired immunodeficiency syndrome and neurotoxoplasmosis. Arq Neuropsiquiatr 62: 1033-1037.
3. Bornard JE, de Gottrau P 1997. Uveitis: is ocular toxoplasmosis only a clinical diagnosis? Ophthalmologica 211: 87-89.
4. Camargo ME 1964. Improved techniques of indirect immunofluorescence for serological diagnosis of toxoplasmosis. Rev Inst Med Trop Sao Paulo 66: 117-118.
5. Desmonts G 1966. Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol 76: 839-851.
6. Fardeau C, Romand S, Rao NA, Cassoux N, Bettembourg O, Thulliez P, Leohang P 2002. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol 134: 196-203.
7. Garweg JG 2005. Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol 27: 61-68.
8. Garweg JG, Garweg SD, Flueckiger P, Jacquier P, Boehnke M 2004. Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M and E in cases of human ocular toxoplasmosis. J Clin Microbiol 42: 4593-4598.
9. Garweg JG, Jacquier P, Boehnke M 2000. Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol 38: 996-1001.
10. Gehlen ML, Dahul VM, Obara SS, Grebos SP, Moreira CA 1999. Incidência e etiologia de uveítes em Curitiba. Arq Bras Oftalmol 62: 622-626.
11. Holland GN 2003. LX Edward Jackson Memorial Lecture. Ocular toxoplasmosis: a global reassessment. Part I: Epidemiology and course of disease. Am J Ophthalmol 136: 973-988.
12. Jain SD, Uppal B, Mehta DK 1998. Seroepidemiology of ocular toxoplasmosis-profile of an urban population. Indian J Pathol Microbiol 419: 387-390.
13. Jones JL, Kruszon-Moran D, Won K, Wilson M, Schantz PM 2008. Toxoplasma gondii and Toxocara spp. Co-infection. Am J Trop Med Hyg 78: 35-39.
14. Katina JH, Oréfice F, Mineo JR 1992. Anticorpos IgA específicos no soro e humor aquoso de pacientes com uveíte de provável etiologia toxoplásmica. Rev Bras Oftalmol 51: 209-214.
15. Knop E, Knop N 2005. The role of associated lymphoid tissue in corneal immune protection. J Anat 206: 271-285.
16. Loyola AM, Durighetto AF Jr, Silva DA, Mineo JR 1997. Anti Toxoplasma gondii immunoglobulins A and G in human saliva and serum. J Oral Pathol Med 26: 187-191.
17. Lynch MI, Cordeiro F, Ferreira S, Ximenes R, Oréfice F, Malagueño E 2004. Lacrimal secretory IgA in active posterior uveítes induced by Toxoplasma gondii. Mem Inst Oswaldo Cruz 99: 861-864.
18. Lynch MI, de Moraes LF, Malagueño E, Ferreira S, Cordeiro F, Oréfice F 2008. Características clínicas de 64 indivíduos portadores de uveitis posterior activa presumiblemente toxoplásmica en Per-nambuco. Arq Bras Oftalmol 71: 43-48.
19. Meek B, Back JW, Klaren VN, Speijer D, Peek R 2002. Conserved regions of protein disulfide isomerase are targeted by natural IgA antibodies in humans. Int Immunol 14: 1291-1301.
20. Meek B, Klaren V, van Haeringer NJ, Kijlstra A, Peek R 2000. IgA antibodies to Toxoplasma gondii in human tears. Invest Ophthalmol Vis Sci 41: 2584-2590.
21. Meek B, Speijer D, de Jong PT, de Smet MD, Peek R 2003. The ocular humoral immune response in health and disease. Prog Retin Eye Res 22: 391-415.
22. Montoya JG, Remington JS 1996. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 23: 277-282.
23. Oréfice F, Garcia LM 2005. Toxoplasmose. In F Oréfice, Uveíte clínica e cirúrgica, 2a ed., Cultura Médica, Rio de Janeiro, p. 724-728.
24. Reis PAC, Campos CM, Fernandez LC 1998. Características da população portadora de visão subnormal do Hospital São Geraldo. Um estudo retrospectivo de 435 casos. Rev Bras Oftalmol 57: 287-294.
25. Sahu PS, Parija SC, Sahu PK 2008. Tear IgA-ELISA: a novel and sensitive method for diagnosis of ophthalmic cysticercosis. Acta Tropica 106: 168-174.
26. Schellini SA, Zambrim MA, Amarante RB, Jorge EC, Silva MR 1993. Toxoplasmose ocular Análise de 100 pacientes tratados na Faculdade de Medicina de Botucatu. Rev Bras Oftalmol 52: 35-40.
27. Sebben JC, Melamed J, Silveira SM, Locatelli CI, Fridman D, Ferreti R 1995. Influência de fatores climáticos na toxoplasmose ocular em Guaraporé Brasil. Rev Bras Oftalmol 54: 303-307.
28. Tonelli E 2000. Toxoplasmose. In E Tonelli, Doenças infecciosas na infância, 2a ed., Medsi, Rio de Janeiro, p. 769-776.
29. Villard O, Filisetti D, Roch-Deries F, Garweg J, Flament J, Candolfi E 2003. Comparison of enzyme-linked immunosorbent assay, immunoblotting and PCR for diagnosis of toxoplasmic chorioretinitis. J Clin Microbiol 41: 3537-4541.